このアイテムのアクセス数: 219
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
j.ijpharm.2021.121185.pdf | 799.58 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Hira, Daiki | en |
dc.contributor.author | Kitagawa, Tomoya | en |
dc.contributor.author | Imamura, Taku | en |
dc.contributor.author | Kakinoki, Masashi | en |
dc.contributor.author | Ueshima, Satoshi | en |
dc.contributor.author | Okano, Tomonobu | en |
dc.contributor.author | Ohji, Masahito | en |
dc.contributor.author | Kakumoto, Mikio | en |
dc.contributor.author | Terada, Tomohiro | en |
dc.contributor.alternative | 平, 大樹 | ja |
dc.contributor.alternative | 寺田, 智祐 | ja |
dc.date.accessioned | 2022-03-24T07:43:10Z | - |
dc.date.available | 2022-03-24T07:43:10Z | - |
dc.date.issued | 2021-11 | - |
dc.identifier.uri | http://hdl.handle.net/2433/268984 | - |
dc.description.abstract | Intravitreal injections of vancomycin (VCM) and ceftazidime (CAZ) are commonly used to treat infectious endophthalmitis. When patient cases require retinal detachment with silicone oil (SO) tamponade, the antibiotic doses are empirically reduced to 25 %. Currently, there is no scientific evidence for these empirical dose reductions. The purpose of the present study is to determine the quantitative impact that SO tamponades have on intraocular VCM pharmacokinetics. Because of high invasiveness of frequent sampling of intraocular VCM concentrations in human, this pharmacokinetic study was performed in cynomolgus monkey’s eyes. Population pharmacokinetic modeling and simulation were performed using 75 different intraocular VCM concentrations obtained from 8 male cynomolgus monkeys. A one-compartment model with a first-order diffusion rate was used as a structural pharmacokinetic model. From the covariate analysis, SO tamponade significantly decreased the volume of distribution while pars plana vitrectomy with lensectomy (PPV) significantly increased the clearance and diffusion rate constants. From the Monte Carlo simulation (n = 1, 000), the median time above minimum inhibitory concentration (T>MIC, a therapeutic effect index) durations of SO and normal eyes at clinical doses of 1, 000 µg were 2.6 and 11.0 days, respectively. Using intravitreal injections of VCM with SO tamponade or PPV may reduce the therapeutic effect. | en |
dc.language.iso | eng | - |
dc.publisher | Elsevier BV | en |
dc.rights | © 2021. This manuscript version is made available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license. | en |
dc.rights | The full-text file will be made open to the public on 20 November 2022 in accordance with publisher's 'Terms and Conditions for Self-Archiving'. | en |
dc.rights | This is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。 | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.subject | Silicone oil tamponade | en |
dc.subject | Vancomycin | en |
dc.subject | Population pharmacokinetics | en |
dc.subject | Infectious endophthalmitis | en |
dc.subject | Pars plana vitrectomy | en |
dc.subject | Lensectomy | en |
dc.title | Impact of silicone oil tamponade on intravitreally injected vancomycin pharmacokinetics in cynomolgus monkey eyes | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.jtitle | International Journal of Pharmaceutics | en |
dc.identifier.volume | 609 | - |
dc.relation.doi | 10.1016/j.ijpharm.2021.121185 | - |
dc.textversion | author | - |
dc.identifier.artnum | 121185 | - |
dc.identifier.pmid | 34655708 | - |
dcterms.accessRights | open access | - |
datacite.date.available | 2022-11-20 | - |
datacite.awardNumber | 20K07211 | - |
datacite.awardNumber.uri | https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20K07211/ | - |
dc.identifier.pissn | 0378-5173 | - |
jpcoar.funderName | 日本学術振興会 | ja |
jpcoar.awardTitle | 実臨床におけるファーマコゲノミクスデータベースを活用した個別化投与設計指針の構築 | ja |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス